Schwartz Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Schwartz Investment Counsel's ABBV Position: Q3 2023 in Review
Schwartz Investment Counsel sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 1,846 shares — an estimated $249K sold.
Schwartz Investment Counsel first reported a position in ABBV in Q2 2013 and held it in 22 quarters. The position peaked at $3.26M in Q4 2013. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Schwartz Investment Counsel reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
- Schwartz Investment Counsel sold 1,846 AbbVie shares in Q3 2023, an estimated $249K.
- Schwartz Investment Counsel first reported a position in AbbVie in Q2 2013 and held it in 22 quarters.
- Schwartz Investment Counsel's AbbVie position peaked at $3.26M in Q4 2013.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Schwartz Investment Counsel's 13F filing for Q3 2023, filed 17 Oct 2023.